Lilly (LLY) Does Not Plan to Submit BLA for Solanezumab to FDA Following EXPEDITION Analysis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. OSIS
9. REAX
10. RMAX

Go back to Lilly (LLY) Does Not Plan to Submit BLA for Solanezumab to FDA Following EXPEDITION Analysis
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1255.40 +11.00 (0.88%)
Previous Close $1244.40    52 Week High $88.16 
Open $1232.00    52 Week Low $67.88 
Day High $1271.22    P/E 290.60 
Day Low $1230.00    EPS $4.32 
Volume 2,505,585